Latest Financials News

Avira Resources has completed its acquisition of the Mt Cattlin Gold Project, validating historical data and advancing plans for a significant drilling program in early 2026, backed by a $2.5 million capital raise.

Freedom Care Group Holdings reports a modest cash increase to $0.5 million but continues to grapple with delayed payments from the NDIA, while exploring options to relist on the ASX.

Freedom Care Group Holdings has revealed ongoing financial distress with key subsidiaries entering liquidation and persistent delays in payments from the NDIA, leaving the company with a diminished cash reserve and a strategic focus on asset sales and cost reduction.

Freedom Care Group Holdings has placed its main operating entity into administration following a sharp decline in cash receipts linked to delayed payments from the NDIA and an ongoing audit. The company’s cash balance dropped significantly, prompting urgent restructuring efforts.

Strike Energy reports steady progress on its South Erregulla gas power project, while optimising Walyering production and maintaining strong liquidity. The company navigates market conditions with a strategic reduction in output and plans for upcoming drilling activities.

Spacetalk Ltd has completed a major pivot from hardware to a scalable software-as-a-service model, driving a 26% increase in active mobile subscribers and a 9% rise in annual recurring revenue to $12 million.

Taruga Minerals has taken a major step forward with a 12-month option to acquire two promising Papua New Guinea projects, backed by a $1.5 million capital raise to accelerate exploration efforts.

Mayne Pharma delivered a robust FY25 performance with a 105% surge in underlying EBITDA and launched key dermatology products as it outlines a strategic growth path for FY26.

Verity Resources has delivered strong drilling results at its Monument Gold Project, secured full ownership of Botswana copper-silver assets, and confirmed significant rare earth mineralisation in Brazil, setting the stage for a pivotal 2026.

BrainChip Holdings has bolstered its financial position with a A$35 million capital raise and commenced volume production of its AKD1500 neuromorphic AI chip, while deepening its strategic partnership with Parsons’ defence arm.

Dimerix Limited has completed recruitment for its pivotal ACTION3 Phase 3 trial targeting a rare kidney disease, secured positive FDA feedback on trial endpoints, and reported a solid cash position of AU$38.5 million at the end of 2025.

OD6 Metals has reported significant progress in its rare earth and copper projects, unveiling a high-recovery processing flowsheet and identifying promising new copper conductors near historic workings.